Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-03

Clinical Trial Update: A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial [NA]

View source ↗

Summary

A prospective evaluation of RiSolve, a prescription digital therapeutic for treating overactive bladder in women, is listed as not yet recruiting in this trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RiSolve Prescription Digital Therapeutic

Snippet

Sponsor: University of Galway | Conditions: Overactive Bladder (OAB), Over Active Bladder | NA | Status: NOT_YET_RECRUITING